Skip to main content

Table 1 Gender-stratified characteristics of MetS patients and healthy control subjects

From: Gender disparity in LDL-induced cardiovascular damage and the protective role of estrogens against electronegative LDL

 

Men

Women

Total

 

Control (n = 11)

MetS (n = 15)

Control (n = 15)

MetS (n = 15)

Control (n = 26)

MetS (n = 30)

Age (years)

41.2 ± 9.8

48.9 ± 7.1*

49.3 ± 15.7

53.2 ± 4.4

45.9 ± 13.9

51.1 ± 6.2*

Waist (cm)

88.5 ± 10.6

106.4 ± 12.9**

74.4 ± 8.0#

106.2 ± 15.2**

80.4 ± 11.5

106.3 ± 13.9**

SBP (mmHg)

121.3 ± 9.6

136.2 ± 16.5*

120.1 ± 26.8

120.2 ± 14.8

120.6 ± 21.0

127.5 ± 17.3

DBP (mmHg)

81.5 ± 10.2

83.4 ± 9.8

73.0 ± 14.6

74.5 ± 9.6

76.6 ± 13.4

78.6 ± 10.5

Glucose (mg/dL)

89.2 ± 7.7

142.7 ± 59.1**

85.1 ± 7.4

102.4 ± 19.4**

86.9 ± 7.6

122.5 ± 47.8**

TC (mg/dL)

232.0 ± 47.8

196.9 ± 48.0

224.9 ± 60.0

220.0 ± 59.1

227.9 ± 54.2

208.5 ± 54.2

TG (mg/dL)

151.8 ± 95.0

180.9 ± 151.8

106.3 ± 95.5

144.1 ± 59.0*

125.6 ± 96.2

162.5 ± 114.7

HDL-C (mg/dL)

52.7 ± 15.8

44.0 ± 12.2

62.1 ± 13.7

54.0 ± 19.2

58.1 ± 15.1

49.0 ± 16.6*

LDL-C (mg/dL)

149.0 ± 37.9

120.9 ± 45.3

142.3 ± 52.1

143.9 ± 41.2

145.2 ± 45.9

132.8 ± 44.0

L5 (%)

4.1 ± 5.3

16.9 ± 14.6**

5.1 ± 5.6

10.1 ± 8.5*

4.7 ± 5.4

13.5 ± 12.2**

  1. Values represent the mean ± standard deviation. P-values were determined by using the Wilcoxon rank sum test (Mann–Whitney U test). MetS metabolic syndrome; SBP systolic blood pressure; DBP diastolic blood pressure; TC total cholesterol; TG triglyceride; HDL-C HDL cholesterol; LDL-C LDL cholesterol. *P < 0.05, **P < 0.01 vs gender-matched control group; #P < 0.05 vs male control group.